{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:51:36Z","timestamp":1762912296459,"version":"3.45.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Global Epidemiology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.gloepi.2023.100108","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T20:48:38Z","timestamp":1682110118000},"page":"100108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The changing profile of SARS-CoV-2 serology in Irish blood donors"],"prefix":"10.1016","volume":"5","author":[{"given":"Dermot","family":"Coyne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dearbhla","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne","family":"Meehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Keogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e1draig","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Carterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tor","family":"Hervig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh","family":"O'Flaherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","author":"WHO","series-title":"Population-based age-stratified seroepidemiological investigation protocol for coronavirus 2019 (COVID-19) infection | COVID-19: surveillance, case investigation and epidemiological protocols","key":"10.1016\/j.gloepi.2023.100108_bb0005"},{"key":"10.1016\/j.gloepi.2023.100108_bb0010","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268821000984","article-title":"Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers","volume":"149","author":"Allen","year":"2021","journal-title":"Epidemiol Infect"},{"year":"2021","author":"HPSC","series-title":"COVID-19 vaccination uptake in Ireland 2021 weekly reports","key":"10.1016\/j.gloepi.2023.100108_bb0015"},{"year":"2022","author":"HPSC","series-title":"Epidemiology of COVID-19 in Ireland","key":"10.1016\/j.gloepi.2023.100108_bb0020"},{"key":"10.1016\/j.gloepi.2023.100108_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.105045","article-title":"Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection","volume":"146","author":"Butler","year":"2022","journal-title":"J Clin Virol"},{"key":"10.1016\/j.gloepi.2023.100108_bb0030","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.gloepi.2023.100108_bb0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/M20-6976","article-title":"The proportion of SARS-CoV-2 infections that are asymptomatic\u202f: a systematic review","volume":"174","author":"Oran","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gloepi.2023.100108_bb0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(20)31483-5","article-title":"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study","volume":"396","author":"Pollan","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.gloepi.2023.100108_bb0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/vox.12995","article-title":"Research initiatives of blood services worldwide in response to the covid-19 pandemic","volume":"116","author":"O\u2019Brien","year":"2021","journal-title":"Vox Sang"},{"key":"10.1016\/j.gloepi.2023.100108_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cid\/ciaa849","article-title":"Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors","volume":"72","author":"Erikstrup","year":"2021","journal-title":"Clin Infect Dis"},{"year":"2020","author":"Slot","series-title":"Herd immunity is not a realistic exit strategy during a COVID-19 outbreak","key":"10.1016\/j.gloepi.2023.100108_bb0055"},{"key":"10.1016\/j.gloepi.2023.100108_bb0060","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S1473-3099(20)30773-8","article-title":"What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2","volume":"21","author":"Hodgson","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.gloepi.2023.100108_bb0065","first-page":"13","article-title":"IgG antibodies develop to spike but not to the nucleocapsid viral protein in many asymptomatic and light COVID-19 cases","author":"Tutukina","year":"2021","journal-title":"Viruses."},{"key":"10.1016\/j.gloepi.2023.100108_bb0070","doi-asserted-by":"crossref","first-page":"576","DOI":"10.17269\/s41997-021-00531-6","article-title":"SARS-CoV-2 seroprevalence among blood donors in Quebec, and analysis of symptoms associated with seropositivity: a nested case-control study","volume":"112","author":"Lewin","year":"2021","journal-title":"Can J Public Health"},{"key":"10.1016\/j.gloepi.2023.100108_bb0075","first-page":"9","article-title":"Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission","author":"Rivett","year":"2020","journal-title":"Elife."},{"key":"10.1016\/j.gloepi.2023.100108_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262442","article-title":"Performance of the Abbott SARS-CoV-2 IgG serological assay in south African 2 patients","volume":"17","author":"Jugwanth","year":"2022","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.gloepi.2023.100108_bb0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/infdis\/jiaa659","article-title":"Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients","volume":"223","author":"Muecksch","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gloepi.2023.100108_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12879-021-05878-2","article-title":"Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections","volume":"21","author":"Eyre","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gloepi.2023.100108_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/irv.12915","article-title":"Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID-19 pandemic","volume":"16","author":"Bergeri","year":"2022","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.gloepi.2023.100108_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00288-21","article-title":"Performance of the Abbott SARS-CoV-2 IgG II quantitative antibody assay including the new variants of concern, VOC 202012\/V1 (United Kingdom) and VOC 202012\/V2 (South Africa), and first steps towards global harmonization of COVID-19 antibody methods","volume":"59","author":"English","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.gloepi.2023.100108_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01402-21","article-title":"The comparability of anti-spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study","volume":"10","author":"Perkmann","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.gloepi.2023.100108_bb0110","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10096-021-04169-7","article-title":"Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting","volume":"40","author":"Muller","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.gloepi.2023.100108_bb0115","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/clinchem\/hvaa198","article-title":"Side-by-side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity","volume":"66","author":"Perkmann","year":"2020","journal-title":"Clin Chem"},{"key":"10.1016\/j.gloepi.2023.100108_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00391-21","article-title":"SARS-CoV-2 antibody testing in health care workers: a comparison of the clinical performance of three commercially available antibody assays","volume":"9","author":"Allen","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.gloepi.2023.100108_bb0125","first-page":"10","article-title":"Evaluation of natural and vaccine-induced anti-SARS-CoV-2 immunity: a comparative study between different groups of volunteers","author":"Schipani","year":"2022","journal-title":"Diseases."},{"key":"10.1016\/j.gloepi.2023.100108_bb0130","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/s41598-022-06629-2","article-title":"mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants","volume":"12","author":"Yu","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.gloepi.2023.100108_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.778243","article-title":"Previous COVID-19 infection and antibody levels after vaccination","volume":"9","author":"Ali","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.gloepi.2023.100108_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2004974","article-title":"Timescales of influenza A\/H3N2 antibody dynamics","volume":"16","author":"Kucharski","year":"2018","journal-title":"PLoS Biol"},{"key":"10.1016\/j.gloepi.2023.100108_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008635","article-title":"Life course exposures continually shape antibody profiles and risk of seroconversion to influenza","volume":"16","author":"Yang","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.gloepi.2023.100108_bb0150","first-page":"223","article-title":"Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis","volume":"5","author":"Byambasuren","year":"2020","journal-title":"Off J Assoc Med Microbiol Infect Dis Canada"},{"key":"10.1016\/j.gloepi.2023.100108_bb0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejim.2021.05.010","article-title":"SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors","volume":"89","author":"Terpos","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.gloepi.2023.100108_bb0160","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1093\/cid\/ciab219","article-title":"Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers","volume":"73","author":"Van Elslande","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gloepi.2023.100108_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2022.115659","article-title":"Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection","volume":"103","author":"Van Elslande","year":"2022","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Global Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590113323000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590113323000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:48:17Z","timestamp":1762912097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590113323000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":33,"alternative-id":["S2590113323000111"],"URL":"https:\/\/doi.org\/10.1016\/j.gloepi.2023.100108","relation":{},"ISSN":["2590-1133"],"issn-type":[{"type":"print","value":"2590-1133"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The changing profile of SARS-CoV-2 serology in Irish blood donors","name":"articletitle","label":"Article Title"},{"value":"Global Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gloepi.2023.100108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100108"}}